九洲药业跌2.21%，成交额1.07亿元，主力资金净流出924.52万元

Core Viewpoint - Jiuzhou Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 40.91% but a recent decline of 8.29% over the past five trading days [1] Financial Performance - For the first half of 2025, Jiuzhou Pharmaceutical reported revenue of 2.871 billion yuan, a year-on-year increase of 3.86%, and a net profit attributable to shareholders of 526 million yuan, up 10.70% year-on-year [2] - The company has distributed a total of 2.183 billion yuan in dividends since its A-share listing, with 1.245 billion yuan distributed in the last three years [3] Stock Market Activity - As of September 23, Jiuzhou Pharmaceutical's stock price was 18.58 yuan per share, with a market capitalization of 16.526 billion yuan [1] - The stock has seen a net outflow of 9.245 million yuan in principal funds, with significant buying and selling activity from large orders [1] Shareholder Information - As of June 30, 2025, Jiuzhou Pharmaceutical had 53,700 shareholders, a decrease of 0.57% from the previous period, with an average of 16,571 circulating shares per shareholder [2] - Major shareholders include Huabao Zhongzheng Medical ETF and other funds, with varying changes in their holdings [3]